This laboratory guide provides a definitive KPV reconstitution chart, volumetric concentration formulas, and handling protocols for high-purity Lysine-Proline-Valine research compounds. Access exact dilution ratios for in vitro cell culture and preclinical animal models while reviewing storage stability criteria.
This laboratory guide provides a definitive KPV reconstitution chart, volumetric concentration formulas, and handling protocols for high-purity Lysine-Proline-Valine research compounds. Access exact dilution ratios for in vitro cell culture and preclinical animal models while reviewing storage stability criteria.
A standard KPV reconstitution chart provides precise volumetric ratios for preparing working stock solutions of Lysine-Proline-Valine (KPV) in laboratory settings. For a standard 5 mg vial of high-purity KPV, adding 1.0 mL of bacteriostatic water yields a concentration of 5.0 mg/mL (5.0 µg/µL). Adding 2.0 mL of diluent yields 2.5 mg/mL (2.5 µg/µL), while 5.0 mL yields 1.0 mg/mL (1.0 µg/µL). Utilizing these exact liquid volumes ensures accurate pipetting during in vitro assays and preclinical animal model administration.
The following reference matrix details common target concentrations based on liquid diluent volume added to lyophilized KPV vials containing 2 mg, 5 mg, or 10 mg of purified peptide sequence:
• 2 mg Vial + 1.0 mL Diluent = 2.0 mg/mL (2.0 µg/µL) • 2 mg Vial + 2.0 mL Diluent = 1.0 mg/mL (1.0 µg/µL) • 5 mg Vial + 1.0 mL Diluent = 5.0 mg/mL (5.0 µg/µL) • 5 mg Vial + 2.5 mL Diluent = 2.0 mg/mL (2.0 µg/µL) • 5 mg Vial + 5.0 mL Diluent = 1.0 mg/mL (1.0 µg/µL) • 10 mg Vial + 2.0 mL Diluent = 5.0 mg/mL (5.0 µg/µL) • 10 mg Vial + 5.0 mL Diluent = 2.0 mg/mL (2.0 µg/µL) • 10 mg Vial + 10.0 mL Diluent = 1.0 mg/mL (1.0 µg/µL)
When performing precision micro-dosing calculations for cell viability assays or receptor-binding studies, researchers should always verify final concentration using the formula: Concentration (µg/µL) = Total Peptide Mass (µg) ÷ Total Reconstitution Volume (µL). Consulting our broader research library provides additional experimental frameworks for non-clinical research designs.
KPV is a tripeptide composed of the amino acid sequence Lysine-Proline-Valine (Lys-Pro-Val). Representing the C-terminal sequence of the endogenous peptide hormone alpha-Melanocyte-Stimulating Hormone (alpha-MSH), KPV retains significant biological signaling capacity while lacking the pigmentary melanocortin-1 receptor (MC1R) activity associated with full-length alpha-MSH fragments.
With a low molecular weight of approximately 384.47 g/mol, KPV displays high aqueous solubility in standard neutral and slightly acidic buffers. The basic lysine residue at the N-terminus imparts a net positive charge at physiological pH, enabling rapid interaction with cellular membranes and peptide transport proteins such as PepT1 (SLC15A1). Understanding these physicochemical parameters is critical when designing volumetric dilutions using a kpv reconstitution chart, as improper pH or ionic strength can alter solution stability over extended experimental timelines.
Reconstitution of lyophilized KPV must be conducted under sterile biosafety cabinet conditions to preserve product purity and prevent microbial contamination. Begin by equilibrating the sealed glass vial to room temperature (20°C to 25°C) for 20 to 30 minutes. Equilibrating reduces vacuum pressure shock and prevents condensation accumulation inside the vial upon opening.
Using an alcohol swab, sanitize the rubber septum of the vial. Using a sterile laboratory syringe, draw the exact volume of diluent—such as sterile bacteriostatic water—specified in your kpv reconstitution chart. Direct the needle tip toward the inner glass wall of the vial, allowing the solvent to stream down slowly rather than spraying directly onto the lyophilized cake. Allow the cake to wet naturally, then gently swirl the vial in a circular motion until completely dissolved. Never vortex or vigorously shake peptide solutions, as mechanical shear stress can disrupt peptide secondary interactions.
To execute accurate bench experiments, researchers must convert mass metrics to microgram volumes using basic volumetric equations. Because 1 milligram (mg) equals 1,000 micrograms (µg), a 5 mg vial contains 5,000 µg of active tripeptide. Reconstituting a 5 mg vial with 2.5 mL (2,500 µg/µL volume ratio) produces a working stock solution where 1 µL contains exactly 2 µg of KPV.
If an in vitro protocol requires a target media concentration of 10 µM in a total volume of 10 mL, researchers utilize the equation C1V1 = C2V2. Given KPV's molecular weight of 384.47 g/mol, a 5 mg/mL stock solution corresponds to a molar concentration of approximately 13.0 mM. Adding 7.69 µL of this stock solution to 10 mL of cell culture media yields the desired 10 µM working concentration. Standardizing these calculations across all research peptides minimizes experimental variability between trial batches.
The choice of diluent directly impacts the chemical stability and biological activity of reconstituted KPV solutions. Standard reconstitution media include Bacteriostatic Water (0.9% benzyl alcohol preserved), Sterile Water for Injection (WFI), and Phosphate-Buffered Saline (PBS, pH 7.4).
Bacteriostatic water is recommended when stock vials will be repeatedly accessed over multiple laboratory days, as the benzyl alcohol prevents bacterial proliferation at refrigerated storage temperatures (2°C to 8°C). For short-term cellular assays where preservatives might interfere with cell line viability, unpreserved sterile water or isotonic PBS is preferred. However, unpreserved aqueous solutions must be aliquoted immediately and stored at -20°C or -80°C to prevent degradation and microbial contamination.
Preclinical investigations demonstrate that KPV acts as a potent modulator of inflammatory signaling cascades without exhibiting systemic immunosuppressive side effects. In vitro assays reveal that KPV enters intestinal epithelial cells via the PepT1 transporter, where it directly interacts with nuclear factor kappa B (NF-κB) pathways. By inhibiting the translocation of p65 NF-κB into the nucleus, KPV suppresses the transcription of pro-inflammatory cytokines, including TNF-alpha, IL-1 beta, and IL-6.
In rodent models of dextran sulfate sodium (DSS)-induced colitis, oral or parenteral administration of KPV attenuated mucosal inflammation, reduced epithelial erosion, and accelerated tight junction restoration. Researchers evaluating gastrointestinal tissue repair frequently compare KPV signaling dynamics against related barrier-modulating compounds to map synergistic pathways.
To select the appropriate scientific tool for barrier integrity and anti-inflammatory research, investigators frequently compare KPV against other prominent tissue-modulating compounds. Below is a structural and functional comparative matrix:
While BPC-157 promotes angiogenesis and tissue healing primarily through VEGF pathway activation, KPV functions primarily as an intracellular NF-κB inhibitor and cytokine suppressor. Researchers studying tight junction dynamics often compare KPV to larazotide acetate, which acts specifically on zonula occludens-1 (ZO-1) assembly, or LL-37, an antimicrobial peptide involved in innate immune responses. For detailed fluid preparation of comparative compounds, refer to our bpc-157 reconstitution chart reference guide.
Lyophilized KPV powder exhibits robust chemical stability when stored in desiccated conditions at -20°C. Under these conditions, the unconstituted peptide remains stable for up to 24 months. Protect lyophilized vials from direct light exposure to prevent photo-oxidation of vulnerable residues.
Once reconstituted with bacteriostatic water, KPV solutions remain stable at 2°C to 8°C for up to 28 days. If reconstituted using unpreserved sterile water or PBS, the solution should be immediately divided into single-use laboratory aliquots using polypropylene microcentrifuge tubes and frozen at -20°C or -80°C. Avoid repeated freeze-thaw cycles, as rapid thermal transitions induce physical aggregation and reduce functional peptide concentration over time.
PX1 Research provides laboratory-grade research compounds manufactured in US-based, GMP-compliant facilities. Every lot of KPV undergoes rigorous quality verification, including Reverse-Phase High-Performance Liquid Chromatography (RP-HPLC) to confirm purity exceeding 99%, and Electrospray Ionization Mass Spectrometry (ESI-MS) to verify molecular weight accuracy.
Furthermore, every lot is subjected to Chromogenic LAL testing to guarantee endotoxin levels remain below strictly controlled thresholds (<0.01 EU/mg), ensuring compatibility with sensitive cell cultures and animal models. All orders ship same-day from our California and Arizona logistics facilities (Monday–Friday). Qualified institutional laboratories and university research centers can request lot-specific Certificates of Analysis (COAs) or apply for wholesale lab accounts for bulk procurement.
kpv reconstitution chart
A standard KPV reconstitution chart specifies diluent ratios for peptide vials. For a 5 mg KPV vial: adding 1.0 mL diluent yields 5.0 mg/mL (5.0 µg/µL); adding 2.5 mL yields 2.0 mg/mL (2.0 µg/µL); adding 5.0 mL yields 1.0 mg/mL (1.0 µg/µL).
What is the standard reconstitution diluent for KPV in research settings?
Bacteriostatic water (0.9% benzyl alcohol) is the standard diluent for multi-use laboratory stock solutions. Sterile water for injection or sterile PBS (pH 7.4) is used for short-term in vitro assays where preservatives might interfere with cell cultures.
How do you calculate KPV concentration in micrograms per microliter (µg/µL)?
Divide the total mass of KPV in micrograms (e.g., 5 mg = 5,000 µg) by the total liquid volume added in microliters (e.g., 2.5 mL = 2,500 µL). In this scenario, 5,000 µg ÷ 2,500 µL = 2.0 µg/µL.
How long does reconstituted KPV remain stable in refrigerated storage?
When reconstituted with bacteriostatic water and stored at 2°C to 8°C, KPV stock solutions maintain chemical stability for up to 28 days. Unpreserved solutions must be aliquoted and frozen at -20°C immediately.
What is the molecular weight of the KPV tripeptide?
The molecular weight of KPV (Lysine-Proline-Valine) is approximately 384.47 g/mol. This value is used to calculate molar concentrations (e.g., mM or µM) for cell culture experiments.
Can KPV be reconstituted directly in phosphate-buffered saline (PBS)?
Yes. KPV exhibits high aqueous solubility in standard neutral PBS (pH 7.4). However, PBS solutions lacking preservatives should be used immediately or frozen in single-use aliquots to prevent contamination.
What preclinical research models utilize the KPV peptide?
KPV is primarily researched in cell culture and rodent models of inflammatory bowel disease (IBD), mucosal gut barrier injury, and systemic inflammatory signaling assays modulating the NF-κB pathway.
Why is vortexing discouraged during KPV reconstitution?
Vortexing or vigorous shaking creates surface tension shear forces that can disrupt peptide conformation or induce physical aggregation. Gentle circular rotation is recommended until dissolved.
What endotoxin levels are verified for PX1 Research KPV?
PX1 Research verifies that endotoxin levels in KPV lots remain below 0.01 EU/mg using Chromogenic LAL testing in ISO 17025 accredited facilities, ensuring suitability for sensitive preclinical assays.
How should lyophilized KPV vials be stored prior to reconstitution?
Unreconstituted lyophilized KPV vials should be stored desiccated at -20°C away from direct light, maintaining full integrity for up to 24 months.
All products are sold strictly for laboratory and research use only. Not for human or veterinary use, diagnosis, treatment or consumption. Statements have not been evaluated by the FDA.